Koki Nakashima

879 total citations
28 papers, 615 citations indexed

About

Koki Nakashima is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Koki Nakashima has authored 28 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 6 papers in Surgery. Recurrent topics in Koki Nakashima's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Koki Nakashima is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Koki Nakashima collaborates with scholars based in Japan. Koki Nakashima's co-authors include Takahiko Tsudzuki, Shosuke Ito, Tatsuya Wakasugi, Junko Tsudzuki, Masahiro Sugiura, Mutsumasa Takahashi, Nobuyuki Sato, S Sumi, Y. YAMASHITA and Kazuhiro Yoshizumi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Koki Nakashima

22 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koki Nakashima Japan	8	358	161	119	114	77	28	615
Karin Johanna Ferrari Italy	8	844 2.4×	29 0.2×	84 0.7×	11 0.1×	52 0.7×	11	1.0k
Bruce Moran Ireland	16	300 0.8×	65 0.4×	22 0.2×	7 0.1×	70 0.9×	42	720
Jianming Liu China	13	319 0.9×	34 0.2×	26 0.2×	8 0.1×	45 0.6×	31	563
A.M. Dutrillaux France	15	252 0.7×	117 0.7×	148 1.2×	5 0.0×	37 0.5×	29	527
Ryoji Fujii Japan	14	242 0.7×	97 0.6×	8 0.1×	15 0.1×	78 1.0×	39	757
Marianne Antoine Germany	14	391 1.1×	9 0.1×	36 0.3×	65 0.6×	22 0.3×	21	575
D. P. Taylor United States	12	125 0.3×	17 0.1×	147 1.2×	36 0.3×	32 0.4×	49	565
Biao Wu China	11	238 0.7×	38 0.2×	60 0.5×	6 0.1×	46 0.6×	35	420
Sergio Botero Colombia	6	194 0.5×	9 0.1×	18 0.2×	116 1.0×	36 0.5×	7	416
M. Stark United Kingdom	7	157 0.4×	49 0.3×	112 0.9×	6 0.1×	78 1.0×	9	386

Countries citing papers authored by Koki Nakashima

Since Specialization

Citations

This map shows the geographic impact of Koki Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koki Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koki Nakashima more than expected).

Fields of papers citing papers by Koki Nakashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koki Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koki Nakashima. The network helps show where Koki Nakashima may publish in the future.

Co-authorship network of co-authors of Koki Nakashima

This figure shows the co-authorship network connecting the top 25 collaborators of Koki Nakashima. A scholar is included among the top collaborators of Koki Nakashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koki Nakashima. Koki Nakashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakashima, Koki, et al.. (2025). An 85-Year-Old Man With Dyspnea and a History of Hormone Therapy for Prostate Adenocarcinoma. CHEST Journal. 168(3). e69–e74.

Nakashima, Koki, et al.. (2025). Bullous Pemphigoid in Patients with Non-small-cell Lung Cancer Complicated by Diabetes Mellitus Receiving Dipeptidyl Peptidase-4 Inhibitors and Immune Checkpoint Inhibitors: A Case Report of Two Patients and Review of Literature. Internal Medicine. 64(20). 2995–2999.

Nakashima, Koki, Yukihiro Umeda, Yoshiki Demura, et al.. (2024). Efficacy of Nanoparticle Albumin-Bound Paclitaxel (nab-PTX) Monotherapy Can Be Improved after Treatment with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: Long-Term Follow-Up and Updated Analysis of Two Previous Prospective Clinical Studies. Oncology. 102(7). 593–603. 3 indexed citations

Nakashima, Koki, Yoshiki Demura, & Tamotsu Ishizuka. (2023). Myelomatous Pleural Effusion: Thoracoscopic Findings. Internal Medicine. 63(11). 1667–1667.

Nakashima, Koki, Yukihiro Umeda, Yoshiki Demura, et al.. (2023). Safety and utility of Endoscopic Ultrasound with Bronchoscope-guided Fine Needle Aspiration (EUS-B-FNA) in suspected lung cancer patients with poor respiratory or general conditions: a prospective three-center observational study. BMC Pulmonary Medicine. 23(1). 206–206. 8 indexed citations

Umeda, Yukihiro, Yoshiki Demura, Koki Nakashima, et al.. (2023). Efficacy and safety of nanoparticle albumin‐bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non‐small cell lung cancer: A multicenter Phase 2 clinical trial. Cancer Medicine. 12(12). 13041–13053. 11 indexed citations

Nakashima, Koki, et al.. (2022). Palliative surgery for malignant superior vena cava obstruction resistant to immunotherapy: a case report. Annals of Palliative Medicine. 12(1). 188–192. 1 indexed citations

Nakashima, Koki, Yasuhiro Sakai, Hitomi Hoshino, et al.. (2022). Sulfated Glycans Recognized by S1 Monoclonal Antibody can Serve as a Diagnostic Marker for Malignant Pleural Mesothelioma. Lung. 200(3). 339–346. 4 indexed citations

Nakashima, Koki, et al.. (2022). Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2022. 1–5. 8 indexed citations

10.

Nakashima, Koki, et al.. (2021). A case of non-small cell lung cancer presenting anti-amphiphysin antibody-positive paraneoplastic neurological syndrome. Respiratory Medicine Case Reports. 34. 101525–101525. 7 indexed citations

11.

Nakashima, Koki, et al.. (2021). Long-Term Survival With Pembrolizumab Re-administration After Pseudo-Progression With Immune-Related Interstitial Lung Disease in a Patient With Non-small Cell Lung Cancer. Cureus. 13(7). e16177–e16177. 1 indexed citations

12.

Nakashima, Koki, et al.. (2021). Xanthomatous Pleuritis Associated With Pancreaticopleural Fistula. Journal of Bronchology & Interventional Pulmonology. 29(2). 155–157. 1 indexed citations

13.

Nakashima, Koki, et al.. (2020). Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab. Internal Medicine. 59(23). 3055–3059. 13 indexed citations

14.

Nakashima, Koki, et al.. (2020). The Association between Malignant Pleural Mesothelioma and Thoracic Radiation Therapy for Hodgkin's Lymphoma: The First Case Report in Japan. Internal Medicine. 60(5). 771–775. 1 indexed citations

15.

Nakashima, Koki, et al.. (2020). Whole-brain Radiation and Pembrolizumab Treatment for a Non-small-cell Lung Cancer Patient with Meningeal Carcinomatosis Lacking Driver Oncogenes Led to a Long-term Survival. Internal Medicine. 59(11). 1433–1435. 6 indexed citations

16.

Nakashima, Koki, et al.. (2020). Utility of Endoscopic Ultrasound with Bronchoscope-guided Fine-needle Aspiration for Detecting Driver Oncogenes in Non-small-cell Lung Cancer during Emergency Situations: Case Series. Internal Medicine. 60(7). 1061–1065. 5 indexed citations

17.

Murakami, Hitoshi, Tateaki Naito, Takehiro Takahashi, et al.. (2016). 456P Practical use of osimertinib in Japanese patients with EGFR T790M mutation positive advanced non-small-cell lung cancer. Annals of Oncology. 27. ix147–ix147.

18.

Arakawa, Akihiko, Tadamasa Yasunaga, S. Yano, et al.. (1993). Radiological findings of retroperitoneal leiomyoma and leiomyosarcoma: Report of two cases. Computerized Medical Imaging and Graphics. 17(2). 125–131. 11 indexed citations

19.

YAMASHITA, Y., Mutsumasa Takahashi, Yukinori Koga, et al.. (1991). Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer. 67(2). 385–391. 111 indexed citations

20.

Yamashita, Yasuyuki, Masamichi Takahashi, Yukinori Koga, et al.. (1990). Prognostic Factors in Liver Metastases after Transcatheter Arterial Embolization or Arterial Infusion. Acta Radiologica. 31(3). 269–274. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact